Abstract:Double-strand breaks (DSBs) can be efficiently removed from the DNA of higher eukaryotes by nonhomologous end-joining (NHEJ). Genetic studies implicate the DNA-dependent protein kinase (DNA-PK) in NHEJ, but the exact function of this protein complex in the rejoining reaction remains to be elucidated. We compared rejoining of DNA DSBs in a human glioma cell line, M059-J, lacking the catalytic subunit of DNA-PK (DNA-PKcs), and their isogenic but DNA-PK-proficient counterpart, M059-K. In both cell lines, rejoining of DNA DSBs was biphasic, with a fast and a slow component operating with a half-life of approximately 22 min and 12 h, respectively. Deficiency in DNA-PK activity did not alter the half-times of either of these components of rejoining but increased from 17 to 72% the proportion of DNA DSB rejoining with slow kinetics. DNA DSB rejoining was nearly complete in both cell lines, and there was only a small increase in the number of unrejoined breaks in M059-J as compared with M059-K cells after 30 h of incubation. Wortmannin radiosensitized to killing M059-K cells and strongly inhibited DNA DSB rejoining. Wortmannin did not affect the radiosensitivity to killing and produced only a modest inhibition in DNA DSB rejoining in M059-J cells, suggesting that, for these end points, DNA-PK is the principal target of the drug. These observations demonstrate that DNA-PK deficiency profoundly decreases the proportion of DNA DSB rejoining with fast kinetics but has only a small effect on the fraction remaining unrejoined. We propose that in higher eukaryotes, an evolutionarily conserved, independently active, but inherently slow NHEJ pathway is stimulated 30-fold by DNA-PKcs to rapidly remove DNA DSBs from the genome. The stimulation is expected to be of local nature and the presence of DNA-PKcs in the vicinity of the DNA DSB determines whether rejoining will follow fast or slow kinetics. Structural and regulatory functions of DNA-PKcs may mediate this impressive acceleration of DNA DSB rejoining, and regions of chromatin within a certain range from this large protein may benefit from these activities. We propose the term DNA-PK surveillance domains to describe these regions.

Autophosphorylation transforms DNA-PK from protecting to processing DNA ends

Differential Phosphorylation of DNA-PKcs Regulates the Interplay Between End-Processing and End-Ligation During Nonhomologous End-Joining

Activation of DNA-PK by hairpinned DNA ends reveals a stepwise mechanism of kinase activation

DNA-PK controls Apollo's access to leading-end telomeres

DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs): Beyond the DNA Double-Strand Break Repair

Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks.

DNA-dependent Protein Kinase Stimulates an Independently Active, Nonhomologous, End-Joining Apparatus.

Structure of an activated DNA-PK and its implications for NHEJ

Structural analysis of the basal state of the Artemis:DNA-PKcs complex

Akt-Mediated Phosphorylation of XLF Impairs Non-Homologous End-Joining DNA Repair

DNA-PKcs: A Multi-Faceted Player in DNA Damage Response

Two distinct long-range synaptic complexes promote different aspects of end processing prior to repair of DNA breaks by non-homologous end joining

Autophosphorylation of the Tousled-like kinases TLK1 and TLK2 regulates recruitment to damaged chromatin via PCNA interaction

Cryo-EM Structure of Human DNA-PK Holoenzyme

HUWE1-dependent DNA-PKcs neddylation modulates its autophosphorylation in DNA damage response

In-Depth Mapping of DNA-PKcs Signaling Uncovers Conserved Features of Its Kinase Specificity

Beyond the Trinity of ATM, ATR, and DNA-PK: Multiple Kinases Shape the DNA Damage Response in Concert With RNA Metabolism

DNA–dependent protein kinase in telomere maintenance and protection

PKA prevents resection of DNA double strand breaks and favor non-homologous end-joining

In-depth mapping of DNA-PKcs signaling uncovers noncanonical features of its kinase specificity

Beyond DNA Repair: DNA-PK Function in Cancer